Orchestra BioMed Holdings, Inc. Deferred Tax Assets, Unrealized Losses on Trading Securities
Orchestra BioMed Holdings, Inc. (OBIO) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $3.10 million as of 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2025-03-31
- 2023-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $3.10M.
- 2022-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $2.91M.
| Period end | Deferred Tax Assets, Unrealized Losses on Trading Securities |
|---|---|
| 2023-12-31 | $3.10M 10-K · filed 2025-03-31 |
| 2022-12-31 | $2.91M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |